KR100986975B1 - Pharmaceutical composition for the treatment of atopic dermatitis - Google Patents

Abstract

Pharmaceutical compositions for treating atopic dermatitis containing plant extracts and foods for alleviating atopic dermatitis, methods for preparing the same are disclosed. The pharmaceutical composition for treating such atopic dermatitis is composed of roots of roots, tuber, pogongyoung and plum extract. Each of the extracts are concentrated to have the same solids content, based on 1 to 60 parts by weight of the root extract of extract, 1 to 60 parts by weight of the extract, 1 to 60 parts by weight of pogongyeong extract and 1 to 60 parts by weight of plum extract do.

Atopy, environmental hormone, plant, treatment

Description

Pharmaceutical composition for the treatment of atopic dermatitis {PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS}

The present invention relates to a pharmaceutical composition for treating atopic dermatitis, and more particularly, to a pharmaceutical composition for treating atopic dermatitis containing a plant extract, and a food for relieving symptoms of atopic dermatitis, and a method for preparing the same. will be.

Atopic dermatitis is a chronic inflammatory skin disease that relieves and worsens. It is also associated with itching, allergic rhinitis and asthma.

The cause of atopic dermatitis is not fully understood, but it is believed to be caused by the following causes. In other words, it is thought to be due to an immune hypersensitivity reaction due to the increase of Ig E, an immunoglobulin associated with allergy, or a lack of T lymphocyte function.

Ig E attaches to mast cells of mucous membranes or skin, and if its concentration is high, histamine is secreted from mast cells to cause inflammation. In most patients with atopic dermatitis, serum Ig E levels are elevated and the clinical severity of atopic dermatitis is found to be proportional.

In this regard, it has been found to secrete cytokines such as IL-4, which induces Ig E production, IL-5, which promotes Ig E production, and IL-6, which amplifies Ig E production. As another factor of atopic dermatitis, free radicals containing free radicals are known. If excessive generation of free radicals occurs, lipid peroxide is generated by reacting with cholesterol or triglycerides of skin cells, thereby moisturizing the stratum corneum. Deterioration in function is sensitive to contact stimuli such as ticks, causing atopic dermatitis.

The cause of such immune hypersensitivity reactions and the excess of free radicals is not clear the root cause, but the function of the immune system due to internal and external stress caused by the influx of environmental hormones such as dioxin due to environmental pollution, in addition to genetic causes It is known to be caused by deterioration and destruction. Secondary bacterial infections associated with atopic dermatitis, increased susceptibility to drug side effects, and decreased resistance to infections such as fungi or viruses.

Treatment for atopic dermatitis has been used to remove allergens or improve the immune system. However, it is difficult to remove allergens. Therefore, the treatment of atopic dermatitis is mainly related to immunity and medications to lower histamine release from mast cells. It's a universal way. Currently used therapeutic methods include immunosuppressive agents to alleviate various symptoms caused by atopic dermatitis, or to apply moisturizers to prevent skin dryness in atopic dermatitis and to treat the accompanying inflammation. I'm using

However, since long-term use of topical corticosteroids causes various skin side effects such as skin atrophy and vasodilation, studies are being actively conducted to develop natural materials having anti-inflammatory effects without showing such side effects.

A prior art derived from natural products utilizing antimicrobial and free radical scavenging ability to alleviate the symptoms of atopic dermatitis includes aloe vera containing antibacterial ingredients that inhibit the proliferation of inflammatory bacteria that further exacerbate dermatitis, a secondary disease of atopic dermatitis. Cosmetics containing Korean green tea and golden extract (Korean Patent Application No. 10-2001-0016162) have been developed and can suppress keratinization of skin tissues and growth of contaminated bacteria by using Ganoderma lucidum and Yujin mushroom, licorice and Baekbongryeong. Herbal cosmetics (Korean Patent Application No. 10-2003-0002827).

In addition, antibacterial and free radicals using mixed extracts of atopic dermatitis alleviating and preventing cosmetics (Korean patent application No. 10-2002- 0060286) containing ginseng extract with bactericidal effect, Gosam and Baekji, Gimo, and leaflet vegetation Anti-inflammatory, moisturizing and anti-inflammatory effects by mixing cosmetics (Korean Patent Application No. 10-2003-0053370) that improves atopy skin with the removal, anti-inflammatory, and moisturizing effects (Pat. , A free radical scavenging effect, such as cosmetics (Korean patent application No. 10-2003-0038851) having the effect of improving the healing of atopic skin, guava extract fermentation, atopy improving composition showing anti-oxidant, antibacterial and anti-inflammatory effects (Korean patent application No. 10-2006-0116279).

In addition, a pharmaceutical composition for preventing or treating a disease caused by excessive histamine including isorienentin present in aloe and bamboo (Korean Patent Application No. 10-2005-0022772) has been reported.

As prior art to the treatment of atopic dermatitis by hypersensitivity of the immune suppression, three hundred seconds (Saururus chinensis ), or an immunosuppressive composition containing (-)-soseneol, soseneol C, manasanthin A or B isolated from the extract as an active ingredient, which effectively inhibits the proliferation of abnormal B cells and T cells, thereby providing excellent immunity. Pharmaceutical compositions and food additives (Korean Patent Application No. 10-2005-0130601) for the prevention and treatment of diseases caused by immune hypersensitivity reactions such as organ transplant rejection, autoimmune diseases, allergies, atopy, etc. A treatment for hypersensitivity skin diseases containing Sanguisorba officinalis extract as an active ingredient, which reduces Ig E, promotes free radical elimination and promotes the proliferation of immune cells, and also has low cytotoxicity. Application No. 10-2005-0024430 is reported.

Also the Gentian Macrophyllae radix) extract is known as a skin disease treatment agent (Korean Patent Application No. 10-2005- 0024429) which has the same effect as fat milk extract. Herbal composition to help atopic dermatitis by regulating cytokine secretion such as Ig E and IL-4 by using Sessin, Cheonoh, Choo, Cheongung, Licorice, Shouo, and Sukwoong (Korean Patent Application No. 10-2005-0026551) This has been reported.

However, the most serious cause of atopic dermatitis is the destruction of the immune system by environmental hormones such as dioxin, which decodes the environmental hormones absorbed in the body and at the same time reduces the Ig E, which causes immune hypersensitivity reactions, and reduces IL-6. There is a demand for producing a novel composition in which a substance that suppresses cytokine secretion, such as and the like, is mixed in an appropriate ratio.

The problem to be solved by the present invention is to provide a pharmaceutical composition for the treatment of atopic dermatitis caused by the disruption of the immune system due to the influx of environmental hormones in the body and a food for relieving symptoms of atopic dermatitis.
In addition, the problem to be solved by the present invention is to provide a pharmaceutical composition and a method for producing the food.

delete

The pharmaceutical composition for treating atopic dermatitis according to an embodiment of the present invention for carrying out such a task is composed of the roots of the roots of the root, the deficiency, pogongyoung and plum. For example, each of the extracts are concentrated to have the same solids content, based on 1 to 60 parts by weight of the root extract, 1 to 60 parts by weight of the extract, 1 to 60 parts by weight poongyoung extract and 1 to 60 parts by weight of plum extract It includes.
For example, each of the above plant extracts may be in a powder form of dried extract.
Foods for alleviating the symptoms of atopic dermatitis according to an embodiment of the present invention contains the roots of the roots of the root, the deficiency, pogongyoung and prune extract. The food may be prepared in the form of powder, tablets, capsules, wire, chewing gum, candy, biscuits, health drinks.
In one embodiment of the present invention, a pharmaceutical composition for treating atopic dermatitis and a method for preparing a food include adding 10 to 30 times the organic solvent to the roots of the roots of the roots of the root, the culprits, the pogongyoung and the plums, and each of the organic solvents added thereto. Extracting and filtering for 2-5 days at 10-30 ° C., filtering the resultant under reduced pressure, drying the resultant under reduced pressure, drying the resultant under reduced pressure, and each of the roots of the root, the deficiency, pogongyoung and plum. Plum extracts are all concentrated to have the same solids content, 1 to 60 parts by weight of the root extract, 1 to 60 parts by weight of the extract, 1 to 60 parts by weight of pogongyeong extract and 1 to 60 parts by weight of the plum extract Steps.
For example, 40 to 90% of an ethanol aqueous solution may be used as the organic solvent.

delete

delete

delete

delete

 The composition according to the present invention has an excellent effect on the prevention and treatment of irritable skin diseases represented by atopic dermatitis without side effects even when taken in large doses as a harmless plant commonly available in the surroundings.

In order to achieve the above object, the present invention provides a natural material, characterized in that it contains four kinds of plant extracts showing the effect of inhibiting inflammation as well as immunomodulatory activity. For example, each of the extracts are concentrated to have the same solids content, based on 1 to 60 parts by weight of the root extract, 1 to 60 parts by weight of the extract, 1 to 60 parts by weight poongyoung extract and 1 to 60 parts by weight of plum extract It may include.

Hereinafter, the present invention will be described in more detail.

Four kinds of plant extract preparations selected in the present invention

The extraction method for four kinds of plants obtained in the present invention is summarized as follows.

Root skin  Extract recipe

Root skin davidiana var.) i.e., the dry elm root bark is crushed with a grinder and 2 to 200 times, preferably 10 to 30 times, organic solvent is added to the volume and 1 to 10 days at 10 to 50 ° C, preferably Extraction may be carried out for 2 to 5 days, filtered, concentrated under reduced pressure, and prepared in a drying step. In this case, ethanol, methanol, dichloromethane, or the like may be used as the extraction solvent, and 40 to 90% aqueous ethanol solution is preferable.

Casper Extract

Cassia obtusifolia ) and then to the organic solvent of 2 to 200 times, preferably 10 to 30 times the volume of the volume is added and extracted for 1 to 10 days, preferably 2 to 5 days at 10 to 30 ℃, filtered and reduced pressure It can be concentrated and prepared in a drying step. In this case, ethanol, methanol, dichloromethane, or the like may be used as the extraction solvent, and 40 to 90% aqueous ethanol is preferable.

Poongyoung Extract  quite

After pulverizing Taraxacum platycarpum, an organic solvent of 2 to 200 times, preferably 10 to 30 times, is added to the volume, and extracted and filtered at 10 to 30 ° C. for 1 to 10 days, preferably 2 to 5 days. After concentration under reduced pressure and may be prepared by a drying step. In this case, ethanol, methanol, dichloromethane, or the like may be used as the extraction solvent, and 40 to 90% aqueous ethanol solution is preferable.

Plum Extract Preparation

Prunus salicina ) nuclei are removed and divided into 4 portions, followed by hot air drying or lyophilization of 50 ° C. or lower, followed by drying, and then an organic solvent of 2 to 200 times, preferably 10 to 30 times, is added to the volume, and 1 to 10 to 30 ° C. The extract may be extracted for 10 days, preferably 2 to 5 days, filtered, concentrated under reduced pressure, and prepared in a drying step. In this case, ethanol, methanol, dichloromethane, or the like may be used as the extraction solvent, and 40 to 90% aqueous ethanol solution is preferable.

Specifically, in the preferred embodiment of the present invention using an extractor equipped with a reflux device extracts while stirring for 72 hours using a 70% aqueous ethanol solution of 10 times with respect to the roots of the root and the defect, pogongyoung, plum or its dried, filtered and filtered The mixture was concentrated under reduced pressure to obtain an ethanol extract, and to the extract, an excipient such as maltodextrin was added to the extract, and lyophilized or spray dried to obtain an extract powder.

Degranulation  Inhibitory effect

Beta-hexosaminidase (β-hexosaminidase) is an inflammatory precursor present with histamine in granules in human mast cell line-1 (HMC-1). When the antigen forms cross linking between the Ig E antibodies bound to the Fc receptor on the surface of the mast cell's membrane, the membrane is activated and degranulated in a short time through enzymatic reaction. Nidase (β-hexosaminidase) and histamine are secreted. Since histamine is present in low concentration in mast cells and goes through several steps, β-hexosaminidase assay was used, which is relatively error-free and stable measurement due to severe analysis variation. .

After culturing HMC-1, the cells were collected by centrifugation, and then, 900 μl was added to a 48 well plate at a concentration of 2 × 10 ⁶ cells / ml in a tyroid buffer. Rooted root skin, diluted to 10 μg / ml and 100 μg / ml in Tyroid buffer, and added to the wells of Cultivator, Pogongyeong, and Prunus extracts in each well, followed by 37 ° C, 5% CO2 incubator After incubation for 30 minutes in a compound, decompactant compound 48/80 (compound 48/80) was added at a concentration of 6 ㎍ / ㎖ again incubated for 30 minutes at 37 ℃, 5% CO2 incubator It was.

The reaction was terminated by placing a 48 well plate in an ice bath for 10 minutes, followed by centrifugation to allow the cells to settle, and 30 μl of the supernatant was transferred to a 96 well plate. 30 μl of 1 mM (p-nitrophenyl-N-acetyl-β-D-glucosaminide) substrate was added to the wells and reacted at 37 ° C. for 1 hour, followed by 120 μl of stop solution (sodium bicarbonate, pH 10.2). Absorbance was measured at 405 nm using an ELISA microplate reader.

The secretion amount of beta hexosaminidase (β-hexosaminidase) was calculated using the following equation (1).

Secretion (%) = B / A x 100

In implantation, A is positive control absorbance and B represents sample treatment absorbance.

The results are summarized in FIG. 1.

In other words, compared to the positive control treated with compound 48/80 (compound 48/80) alone, degranulation was significantly suppressed at 95% level when 10ug / ml of Lactobacillus, Rhizome vulgaris, pogongyeong, and plum extracts were treated. , 100ug / ml treatment significantly inhibited degranulation at 99% level in all treatments.

Composition ratio of mixed extract for improving symptoms of skin disease

Four kinds of drugs that can help skin diseases by inhibiting the release of β-hexosaminidase and histamine by degranulation of human mast cells in response to foreign antigens Plant extracts, that is, the roots of the root and the deficiency, poongryong, plum extract, etc., respectively, were mixed in the same component ratio to complete the natural product preparation according to the present invention. As a result of measuring beta hexosaminidase secretion ability using the natural product according to the present invention, the effect was superior to using each plant extract alone (FIG. 2). In other words, even at 1ug / ml level, significance was recognized at the level of 95%, and degranulation inhibitory effect was stronger as treatment concentration was increased.

Immune activity ( cytokines  Secretion inhibitory effect)

 In most patients with atopic dermatitis, immune hypersensitivity reactions increase serum Ig E levels and secrete cytokines such as IL-6 which amplify the production of Ig E. Therefore, the secretion amount of cytokines related to immune activity was confirmed using the natural product according to the present invention, which was found to inhibit the degranulation in Example 3.

That is, HMC-1 was dispensed in a 24-well plate at a concentration of 3 × 10 ⁶ cells / ml in IMDM, and the sample diluted to the concentration of 1 ㎍ / mL, 10 ㎍ / mL, 100 ㎍ / mL mixed extract was prepared. Incubated for 30 minutes in a 37 ° C., 5% CO ₂ incubator, followed by adding 40 nM of phorbol 12-myristate 13-acetat and 1 uM of Calcium ionophore A23187I to 37 ° C., 5% CO ₂ incubator. Incubated for 4 hours in an incubator and then centrifuged at 1,200 rpm for 5 minutes to obtain a supernatant.

Quantification of TNF-α, IL-6, and IL-8 using this supernatant was quantified using Quantikine kit (R & D systems, cat. DTA00C) and confirmed by reverse transcriptaes-polymerase chain reaction (RT-PCR). The results are shown in Figures 3a, 3b and 3c. In other words, TNF-α was found to be significantly lowered when treated at concentrations above 1ug / ml at the 95% significance level, but the inhibitory power was not significantly different even when the concentration was increased.

In the case of IL-6, as shown in Figure 3b it was significantly decreased when the concentration of 1ug / ml or more at 95% significance level, but at 10ug / ml did not show a difference according to the increase in concentration, significantly reduced at 100ug / ml treatment Appeared to be. In the case of IL-8, similar to TNF-α, the treatment was significantly lowered when the concentration was above 1 ug / ml at the 95% significance level, but the inhibition was not significantly different even when the concentration was increased.

Anti-inflammatory efficacy evaluation

 Six-week-old NC / Nga mice, known as atopy-induced models, were used for four days after adaptive breeding for seven days. In the untreated group, atopic dermatitis treated group and atopic dermatitis treated group, the natural product according to the present invention was 1.667 mg / kg / day (0.1 g per day for 60 kg body weight), 16.67 mg / kg / day, 166.7 mg / Experiments were divided into test groups administered orally by kg / day.

Each sample was orally administered at the same time every day, and the control group was administered by weight in the same manner as mice receiving PBS sample containing 1% DMSO. In addition, 10 μl of house dust mite ( Dermato - phagoides farinae (DF)) was applied to both ears at a concentration of 5 mg / ml once every two days using antigen as an antigen. Ear thicknesses were measured using vernier calipers prior to application of the antigen every other day to determine inflammation. The experimental results are as shown in FIG.

In other words, when oral administration for more than 1.667mg / ㎏ / day for 4 weeks, the inflammation was significantly inhibited at 95% level compared to the atopy-induced substance treatment group.

Figures 5a to 5d is a result of observing the tissue by hematoxylin and eosin staining the ear tissue in order to determine the effect of the feed of the natural product according to the present invention on the tissue of the ear after atopic dermatitis treatment. In more detail, 5a is the normal group (NC), 5b is the atopic dermatitis treatment group (NC), 5c is fed 1.667 mg / kg / day, 5d is fed 1.667 mg / kg / day, 5e is Picture of ear tissue from group fed at 166.7 mg / kg / day.

As can be seen from the micrographs of FIGS. 5A to 5E, edema occurred in the atopic dermatitis treated group (PC) compared to the normal group (NC), indicating that the tissue became thick and destroyed. And as the treatment concentration of the natural product according to the present invention increased the thickness of the ear was confirmed that the tissue is also normalized.

Blood of the Experimental Animal Ig  Measurement of E

6 is a result of measuring the concentration of Ig E related to the induction of atopic dermatitis by taking the serum of NC / Nga mice (mice) tested for 4 weeks. In other words, when orally administered with atopic dermatitis and the natural product according to the present invention 1.667mg / kg / day, compared to the PC group treated with only atopic dermatitis, the effect of Ig E was reduced at the 95% significance level and 16.67. Above MG / kg / day, Ig E concentration was different from that of normal group without atopic dermatitis, but it was shown to inhibit Ig E secretion significantly compared to PC group at 99% level.

Clinical trial

The results of a questionnaire for the general public with atopic dermatitis after receiving 500 mg / day of the natural product according to the present invention for 4 weeks and confirming the therapeutic effect thereof (FIG. 7). The number of questionnaires was evaluated as 7 points in the most serious cases and 1 point at all using the 7-point scale method as follows.

1.How much itching and tingling after using soap or cosmetics?

2. In the season of pollen, how much is itching or redness compared to other seasons?

3. What is the extent of itching or redness when sweating on the folds of arms or neck wrinkles?

4. Is your skin dry, especially if it dries more?

5. What is the extent of itching in the affected area?

6. After scratching the skin, what is the extent of itching or redness?

7. After scratching the skin, how much of the scratch is inflamed?

8. After scratching your skin, how much of the skin does it get on?

9. Have you ever scratched the affected area to bleed or sleep when itching to sleep?

10. Does itching or inflammation of the affected area become more severe after going out on a dusty day?

As shown in Figure 7, it was found that the symptoms related to atopic dermatitis in all items were alleviated when ingested 500 mg of the natural product according to the present invention to a general person with atopic dermatitis for 4 weeks.

[Manufacture example 1] Powder

Rhizome Skin and Clarifier, Pogongyoung, Plum Extract 2g

1g lactose

The above ingredients are mixed and filled in an airtight cloth to prepare a powder.

Preparation Example 2 Tablet

Radix Cortex and Clarifier, Pogongyoung, Plum Extract 100mg

Lactose 100mg

Corn Starch 100mg

2 mg magnesium stearate

After mixing the above components, it is compressed according to a conventional tablet production method to prepare a tablet.

[Manufacture example 3] Capsule

Radix Cortex and Clarifier, Pogongyoung, Plum Extract 100mg

Lactose 100mg

Corn Starch 100mg

2 mg magnesium stearate

After mixing the above components to fill a gelatin capsule in accordance with the conventional capsule preparation method to prepare a capsule.

[Production Example 4] Wire

After roasting 40% brown rice, 30% barley, 20% barley, and 10% alpha fine powder, a grain size powder of 60 mesh is produced by a grinder.

40% of black beans, 30% of black sesame seeds, and 30% of perilla seeds are roasted, and a seed grain powder having a particle size of 60 mesh is made with a grinder.

Root skin of the present invention and the deficiency, pogongyoung, plum extract to make a dry powder using a spray dryer.

75% of the grains prepared above, 20% of the seeds and 5% of dry powder of the roots of the roots of the roots and the cultivars, Pogongyoung, and prune extracts are granulated and then granulated.

[Manufacture example 5] Chewing gum

Chewing gum is prepared in a conventional manner by combining gum base 20%, sugar 76%, fragrance 1.5% and water 2%, and the root of the present invention and the root of the present invention, poongyoung, plum extract 0.5%.

[Manufacture example 6] Candy

Candy is prepared in a conventional manner by containing 60% of sugar, 39% of starch syrup and 0.5% of fragrance, and 0.5% of the roots of the present invention and the deficiency, pogongyoung, and plum extract of the present invention.

[Manufacture example 7] Biscuits

Force 1st class 25%, gravity 1st class 23%, white sugar 6%, salt 1%, palm shortening 13%, milk flavor 0.1%, substitute milk powder 3%, spray oil 7% and water 16.9% To prepare biscuits in a conventional manner by combining, poongyoung, plum extract 5%.

[Manufacture example 8] Healthy drink

5% by weight of honey, 3% fructose, 0.0001% of sodium riboflavin hydrochloride, 0.0001% of pyridoxine hydrochloride, and 86.9998% of water together with 5% of the roots of the present invention and the leaves of the present invention, pogongyoung, and plum extract are prepared in a conventional manner. .

[Manufacture example 9] health functional food

15% octacosanol powder, 15% lactose hydrolyzate powder, 15% isolated soy protein powder, 15% chitooligosaccharide 15% yeast extract powder, 10% vitamin mineral mixture, magnesium stearate 4.6%, titanium dioxide 0.2%, and glycerin fatty acid ester 0.2 Tablets and dietary supplements are prepared in a conventional manner by combining% and 20% of the roots of the present invention and the deficiency, pogongyoung, plum extract.

While the present invention has been described in connection with what is presently considered to be practical and exemplary embodiments, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention. Therefore, the above description and the drawings below should be construed as illustrating the present invention, not limiting the technical spirit of the present invention.

1 is a graph showing the change in secretion amount of beta hexosaminidase (β-hexosaminidase) according to the plant extract treatment concentration.

Figure 2 is a graph showing the change in secretion amount of beta hexosaminidase (β-hexosaminidase) according to the treatment concentration of the natural product according to the present invention.

Figure 3a is a graph showing a change in the amount of TNF-α secretion according to the treatment concentration of the natural product according to the present invention.

Figure 3b is a graph showing the change in IL-6 secretion according to the treatment concentration of the natural product according to the present invention.

Figure 3c is a graph showing the change in IL-8 secretion according to the treatment concentration of the natural product according to the present invention.

Figure 4 is a graph showing the effect of feeding the natural product preparation according to the present invention on the ear thickness of the atopic dermatitis-treated mice.

Figures 5a to 5d are micrographs showing the effect of feeding the natural product preparations according to the present invention on the tissue of the ear after atopic dermatitis treatment.

Figure 6 is a graph showing the effect of feeding the natural product preparation according to the present invention on the Ig E concentration in the blood of the mouse after atopic dermatitis treatment.

7 is a graph showing the effect of ingestion of natural products according to the present invention on atopic dermatitis symptoms.

Claims (8)

Consisting of the root extract of the roots, the extract of the deficiency, pogongyeong extract and plum extract, Each of the extracts are all concentrated to have the same solids content, based on 1 to 60 parts by weight of the root extract, 1 to 60 parts by weight of the extract, 1 to 60 parts by weight of pogongyeong extract and 1 to 60 parts by weight of plum extract A pharmaceutical composition for treating atopic dermatitis. delete The pharmaceutical composition for treating atopic dermatitis according to claim 1, wherein each plant extract is in a dry powder state. Consisting of the root extract of the roots, the extract of the deficiency, pogongyeong extract and plum extract, Each of the extracts are all concentrated to have the same solids content, based on 1 to 60 parts by weight of the root extract, 1 to 60 parts by weight of the extract, 1 to 60 parts by weight of pogongyeong extract and 1 to 60 parts by weight of plum extract Food to relieve atopic dermatitis symptom to do. 5. The food for alleviating the symptoms of atopic dermatitis according to claim 4, wherein the food is in the form of a beverage. Adding 10 to 30 times the organic solvent to the roots of the roots of the roots, the stem, the pogongyoung and the plums, respectively; Extracting and filtering each of the roots of the roots of the organic solvent, the clarifier, the pogongyoung and the plums for 2 to 5 days at 10 ° C. to 30 ° C .; Concentrating the resultant after the filtration under reduced pressure; Drying the resultant of the vacuum concentration; And 1 to 60 parts by weight of extract of root roots, 1 to 60 parts of root extract, 1 to 60 parts of root extract and 1 to 60, based on the concentration of each of the roots of the roots of the roots of the root, each of the tuber, pogongyoung and plum extract A method for producing a pharmaceutical composition for treating atopic dermatitis, comprising mixing a part by weight of plum extract. According to claim 6, wherein the organic solvent is a method for producing a pharmaceutical composition for treating atopic dermatitis, characterized in that 40 to 90% aqueous solution of ethanol. delete

Images